Skip to main content
OpenTrials
Completed

NCT Number: NCT02824367

Evaluation of Clinical Perfectionism in Parkinson Disease

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Parkinson Disease Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Synucleinopathies

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU Amiens

Amiens, 80054, France

About this study

Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety. Also, clinicians reported that they exhibit specific personality traits (e.g., rigidity and perfectionism).

To date, few studies used Cognitive Behavioural Therapies (CBT) in people with Parkinson's disease showing promising results. Recently, perfectionism has received particular attention because of it association with many emotional disorders. Thus, some psychometric tools have been developed in order to evaluate different aspects of perfectionism. Yet, none of them has been used in people with Parkinson's disease.

The objective of this study is to investigate whether there is a direct link between Parkinson's disease and perfectionism by using psychometric tools from the CBT literature. Identifying such link would allow to justify the use of CBT in people with Parkinson's disease with the goal in mind to improve their care and quality of life.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than 18 years
  • Score Mini Mental Scale (MMS) greater than 23
  • For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
  • The control patients present dystonias not within the scope of Parkinson
  • Informed Consent Form signed
  • Patient covered by social insurance

Exclusion criteria

  • Proven Presence of neuropsychological disorders
  • Patients with deep brain stimulation
  • Diagnosis of somatic pathology diagnosed
  • Private Patient freedom or protected adult (under guardianship)

Treatment and study plan

Completion of scales evaluation

Behavioral

Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))

Primary outcomes

  1. Perfectionism evaluation 1

    Time frame: Day 0

    Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)

  2. Perfectionism evaluation 2

    Time frame: Day 0

    Hewitt Multidimensional Perfectionism Scale (HMPS).

Secondary outcomes

  1. Depression and anxiety evaluation 1

    Time frame: Day 0

    Scores to depression scale (Beck Depression Inventory (BDI))

  2. Depression and anxiety evaluation 2

    Time frame: Day 0

    anxiety scale (State Trait Anxiety Inventory (STAI))

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire, Amiens

Other

Registry information

Acronym: EPMP-1

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Jul 6, 2016
Registry last updated
Jun 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.